These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17611550)

  • 21. A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.
    Teoh H; Després JP; Dufour R; Fitchett DH; Goldin L; Goodman SG; Harris SB; Langer A; Lau DC; Lonn EM; Mancini GB; McFarlane PA; Poirier P; Rabasa-Lhoret R; Tan MK; Leiter LA
    Diabetes Obes Metab; 2013 Dec; 15(12):1093-100. PubMed ID: 23683111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
    Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
    Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom.
    MacDonald TM; Morant SV
    Br J Clin Pharmacol; 2008 May; 65(5):775-86. PubMed ID: 18279464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Description of the sample, design and methods of the study for the identification of the Spanish population at cardiovascular and renal risk (IBERICAN)].
    Cinza Sanjurjo S; Llisterri Caro JL; Barquilla García A; Polo García J; Velilla Zancada S; Rodríguez Roca GC; Micó Pérez RM; Martín Sánchez V; Prieto Díaz MÁ;
    Semergen; 2020; 46(1):4-15. PubMed ID: 31870705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ["Initiative" in primary care: survey on hypertension prevalence and definition of cardiovascular risk profile in ASL 3 of Lagonegro (PZ)].
    Damiani G; De Fino M; Federico B; Trani F; Pennelli S; Ricciardi G
    Ann Ig; 2006; 18(2):137-45. PubMed ID: 16649511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of medications and lifestyles of hypertensive patients with high risk of cardiovascular disease in rural China.
    Zou G; Zhang Z; Walley J; Gong W; Yu Y; Hu R; Yin J; Yu M; Wei X
    PLoS One; 2015; 10(5):e0124484. PubMed ID: 25932640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of modifiable cardiovascular risk factors in German adolescents.
    Müller-Riemenschneider F; Nocon M; Willich SN
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):204-10. PubMed ID: 19996972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease].
    Cordero A; Bertomeu-Martínez V; Mazón P; Fácila L; Bertomeu-González V; Cosín J; Galve E; Núñez J; Lekuona I; González-Juanatey JR
    Rev Esp Cardiol; 2011 Jul; 64(7):587-93. PubMed ID: 21640460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.
    Ahola TL; Kantola IM; Mäki J; Reunanen A; Jula AM
    Eur J Prev Cardiol; 2012 Aug; 19(4):712-22. PubMed ID: 21609976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension.
    Jackson JH; Frech F; Ronen R; Mullany L; Lennert B; Jhaveri V
    J Manag Care Pharm; 2004; 10(6):513-20. PubMed ID: 15548123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total cardiovascular risk: a new treatment concept.
    Mancia G
    J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The magnitude of atherogenic dyslipidaemia among geriatric Nigerians with systemic hypertension in a rural hospital in Eastern Nigeria.
    Iloh GU; Ofoedu JN; Amadi AN; Obikwu CE
    Niger J Med; 2012; 21(3):320-5. PubMed ID: 23304929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stratification and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study].
    Martín-Baranera M; Campo C; Coca A; de la Figuera M; Marín R; Ruilope LM;
    Med Clin (Barc); 2007 Jul; 129(7):247-51. PubMed ID: 17683705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing from CHD to CVD risk-based guidelines for the management of mild uncomplicated hypertension in different ethnic groups: implications for primary care.
    Gomez GB; Kerry SM; Oakeshott P; Rowlands G; Cappuccio FP
    J Hum Hypertens; 2005 Apr; 19(4):321-4. PubMed ID: 15674404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.